Potential Treatment for Neuropsychiatry Disorders with TRPC5 Modulators
نویسندگان
چکیده
منابع مشابه
Neuropsychiatry of movement disorders
Movement disorders include both psychiatric illnesses with neurologic features and neurologic illnesses with frequent psychiatric complications. During 1998, neuropsychiatric progress was made on several fronts, notably in parkinsonism and tic disorders. This remains an exciting area for research, with many unsolved, clinically important problems, but increasing neurobiologic knowledge and soph...
متن کاملHematopoietic modulators as potential agents for the treatment of leukemia.
Leukemias are the most common malignancy of childhood and have the highest mortality among aging people. Leukemias are a group of blood disorders characterized by an accumulation of leukemic cells in the peripheral blood of patients as a result of disturbances in proliferation and differentiation. Refractory leukemia remains the most common therapeutic challenge. In recent years, the presence o...
متن کاملEditorial: Neuropsychology and Neuropsychiatry of Neurodegenerative Disorders
Unidad de Neurología, Hospital Álvarez-Buylla, Mieres, Spain, Departamento de Morfología y Biología Celular, Universidad de Oviedo, Oviedo, Spain, 3 Instituto de Neurociencias del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain, 4 Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile, Departamento de Psicología, Universidad de Oviedo, Oviedo, Spain, Neuropsi...
متن کاملSirukumab: A Potential Treatment for Mood Disorders?
Convergent evidence indicates that abnormalities in the innate immune system may be pertinent to the pathogenesis, phenomenology, and possible treatment of several mental disorders. In keeping with this view, the targeting of interleukin-6 with the human monoclonal antibody sirukumab may represent a possible treatment and disease modification approach, for adults with brain-based disorders (e.g...
متن کاملPositive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.
Studies utilizing selective pharmacological antagonists or targeted gene deletion have demonstrated that type 5 metabotropic glutamate receptors (mGluR5) are critical mediators and potential therapeutic targets for the treatment of numerous disorders of the central nervous system (CNS), including depression, anxiety, drug addiction, chronic pain, Fragile X syndrome, Parkinson's disease, and gas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ACS Medicinal Chemistry Letters
سال: 2016
ISSN: 1948-5875,1948-5875
DOI: 10.1021/acsmedchemlett.6b00182